glycidyl nitrate has been researched along with Sarcoma 180 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floc'h, F; Jollès, P; Maral, R; Migliore-Samour, D; Werner, GH | 1 |
| Abe, C; Homma, JY; Tanamoto, K | 1 |
| Inoue, K; Kadoya, S; Korenaga, H; Sakamoto, N; Tanaka, NG | 1 |
| Kozlov, LV; Lomaka, TS; Rostovtseva, LI; Sorokina, IB; Sutovskaia, NS | 1 |
1 review(s) available for glycidyl nitrate and Sarcoma 180
| Article | Year |
|---|---|
[Chemical and biological properties of the protein moiety of endotoxin of Pseudomonas aeruginosa (author's transl)].
Topics: Amino Acid Sequence; Animals; Antigens, Bacterial; Bacterial Proteins; Cell Wall; Endotoxins; Escherichia coli; Interferon Inducers; Lipopolysaccharides; Mice; Peptidoglycan; Pseudomonas aeruginosa; Sarcoma 180; Structure-Activity Relationship | 1976 |
3 other study(ies) available for glycidyl nitrate and Sarcoma 180
| Article | Year |
|---|---|
Low molecular weight water-soluble peptidoglycans as adjuvants and immunostimulants.
Topics: Adjuvants, Immunologic; Animals; Antibody-Producing Cells; Antigens; B-Lymphocytes; BCG Vaccine; Carcinoma, Ehrlich Tumor; Graft vs Host Reaction; Leukemia; Lymphocyte Transfusion; Molecular Weight; Mycobacterium; Mycobacterium bovis; Neoplasm Transplantation; Peptidoglycan; Phagocytosis; Sarcoma 180; Solubility; T-Lymphocytes; Transplantation, Homologous | 1975 |
The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate.
Topics: Allantois; Animals; Chick Embryo; Chorion; Cortisone; Drug Synergism; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Peptidoglycan; Polysaccharides; Sarcoma 180 | 1988 |
[Effect on human complement of blastolysin and the glycopeptide (MDP and GMDP) and carbohydrate fragments of peptidoglycans].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Complement Activating Enzymes; Complement C3-C5 Convertases; Complement Factor B; Complement Inactivator Proteins; Glycopeptides; Humans; In Vitro Techniques; Mice; Peptidoglycan; Sarcoma 180 | 1985 |